Matthew A. Karlyn is a partner in the firm’s Technology Transactions Group. He represents clients in a wide range of industries including life sciences, healthcare, IT services, manufacturing, software, and energy.
With more than 20 years of experience in technology transactions, including outsourcing and licensing, Mr. Karlyn has worked with clients on IP and technology licenses, strategic partnerships, collaboration agreements, joint development agreements, distribution agreements, manufacture and supply relationships, significant software deployments, data center transactions, and numerous information technology and business process outsourcing transactions. Mr. Karlyn regularly advises his clients with respect to transactions designed to maximize the value of corporate assets.
Mr. Karlyn represents numerous clients in the life sciences and technology sectors, including pharmaceutical, medical device, and software companies. His clients range from Fortune 100 companies to start-ups, and he regularly advises companies on matters involving IP commercialization, complex collaboration transactions, licensing initiatives, subscription-based economics, and business transactions related to the procurement, development, commercialization, and use of technology and life sciences products. He has also worked with a number of clients on corporate transactions including mergers and acquisitions, as well as private equity and venture capital financing.
Mr. Karlyn is a frequent author and speaker on topics pertaining to drafting and negotiating commercial technology, outsourcing, and licensing transactions. He has published over 25 articles (including chapters in two books), given over 175 presentations on licensing, technology, outsourcing, and data security, and is the co-author of A Guide to IT Contracting: Checklists, Tools, and Techniques.
Mr. Karlyn served as chair of the New England Chapter of the International Association of Outsourcing Professionals, and served for five years on the board of directors of Julie’s Family Learning Program, a wellness program for mothers and children in South Boston.Show More
Represent Adagene, a clinical stage biotech company, in a material transfer and research relationship associated with Adagene’s proprietary materials, with a major university.
Represented Vizgen in a university licensing transaction to support Vizgen’s gene profiling instrumentation and data analysis, with a major university.
Represented CareDx, a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, in licensing and research collaboration agreements with a major university, and in a material transfer agreement to support a feasibility study with CRISPR Therapeutics.
Represented clients in licensing and other commercial life sciences transactions adverse to a number of universities including Harvard, MIT, Cornell, Stanford, University of California-San Diego, University of California-Berkeley, University of Pittsburgh, University of Michigan, Tufts, and Northeastern.
Represented BluesphereBio in all licensing matters, including pending deals with a major university and the university's medical center.